Skip to main content
An official website of the United States government

Early Detection Research Network (EDRN)

The Early Detection Research Network (EDRN) is a collaborative program that maintains comprehensive infrastructure and resources critical to the discovery, development and validation of biomarkers for cancer risk and early detection.

The DCP Cancer Biomarkers Research Group administers this program.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About EDRN

The program comprises a public/private sector consortium to accelerate the development of biomarkers that can improve medical practice, ensure data reproducibility and integrity, and adapt to the changing landscape of biomarker science.

Visit the EDRN Website

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Dryden-Peterson, Scott

Brigham And Women'S Hospital
United States

Botswana CASCADE Clinical Trials Site 3UG1CA275416-04S1 Maria Silvina Frech, Ph.D., M.S.
Duan, Bin

University Of Nebraska Medical Center
United States

Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain 1R21CA298918-01 Rachel Altshuler, Ph.D.
Duan, Bin

University Of Nebraska Medical Center
United States

Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain 1R21CA298918-01 Rachel Altshuler, Ph.D.
Duan, Bin

University Of Nebraska Medical Center
United States

Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain 1R21CA298918-01 Rachel Altshuler, Ph.D.
Duncavage, Eric J

Washington University
United States

Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes 4UH3CA272904-02 Nicholas Hodges, Ph.D.
Duvall, Adam S.

University Of Chicago
United States

Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant 1R34CA297498-01 Brennan Streck, Ph.D., RN, M.P.H.
Duvall, Adam S.

University Of Chicago
United States

Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant 1R34CA297498-01 Brennan Streck, Ph.D., RN, M.P.H.
Duvall, Adam S.

University Of Chicago
United States

Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant 1R34CA297498-01 Brennan Streck, Ph.D., RN, M.P.H.
Eastham, James A

Sloan-Kettering Inst Can Research
United States

Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers 5U01CA266535-04 Claire Zhu, Ph.D.
Eibl, Guido Erwin Michael

University Of California Los Angeles
United States

Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma 5P01CA236585-05
Eickhoff, Jens

University Of Wisconsin-Madison
United States

CP-CTNet Coordinating Center 1UG1CA304955-01 Donald Johnsey
Eisenmann, Eric Daniel

Ohio State University
United States

Damage-associated molecular patterns in chemotherapy toxicity 1R37CA299879-01 Rachel Altshuler, Ph.D.
Eisenmann, Eric Daniel

Ohio State University
United States

Damage-associated molecular patterns in chemotherapy toxicity 1R37CA299879-01 Rachel Altshuler, Ph.D.
El-Bayoumy, Karam E

Pennsylvania State Univ Hershey Med Ctr
United States

Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies 5R01CA173465-10 Gabriela Riscuta, M.D., CNS
El-Serag, Hashem B

Baylor College Of Medicine
United States

Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome 5P01CA263025-04 Asad Umar, D.V.M., Ph.D.